NCT05807204View on ClinicalTrials.gov

Effect of a Multi-ingredient on Visceral Adiposity and Non-alcoholic Fatty Liver Disease in Individuals With Abdominal Obesity

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

December 20, 2023

Study Completion Date

January 11, 2024

Conditions
Visceral ObesityNon-Alcoholic Fatty Liver Disease
Interventions
DIETARY_SUPPLEMENT

Multi-ingredient of L-histidine, L-serine, L-carnosine and N-Acetylcysteine

The product will be presented in powder format in a single container and with a measuring spoon of the daily dose.

DIETARY_SUPPLEMENT

Placebo

The product will be presented in powder format in a single container and with a measuring spoon of the daily dose.

Trial Locations (1)

43204

Eurecat, Reus

All Listed Sponsors
collaborator

Centre de Diagnosi per la Imatge

UNKNOWN

collaborator

Laboratorio de Referencia Sud

UNKNOWN

collaborator

Centro OWLiver

UNKNOWN

lead

Fundació Eurecat

OTHER

NCT05807204 - Effect of a Multi-ingredient on Visceral Adiposity and Non-alcoholic Fatty Liver Disease in Individuals With Abdominal Obesity | Biotech Hunter | Biotech Hunter